참고문헌
- Cetin B, Berk V, Kaplan MA,, et al (2013). Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastaticrenal cell carcinoma? Clin Genitourin Cancer, 11, 141-8. https://doi.org/10.1016/j.clgc.2012.09.001
- Ceylan C, Doluoglu OG, Keles I,et al (2014). Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors. Urologia, 81, 120-4. https://doi.org/10.5301/uro.5000031
- De La Roca RL, Da Cunha IW, Bezerra SM, Da Fonseca FP (2014). Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. Int Braz J Urol, 40, 306-15. https://doi.org/10.1590/S1677-5538.IBJU.2014.03.03
- Eerola AK, Soini Y, Paakko P (2006). A high number of tumorinfiltrating lymphocytes are associated with a small tumor size, low tumor stage and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res, 6, 1875-81.
- Fichtner J (2000).The management of prostate cancer in patients with a rising prostate-specific antigen level. BJU Int, 86, 181-90.
- Fondevila C, Metges JP, Fuster J et al(2004). P53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer, 90, 206-15. https://doi.org/10.1038/sj.bjc.6601455
- Hermanns T, Bhindi B, Wei Y, et al (2014). Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radicalcystectomy for urothelial carcinoma of the bladder. Br J Cancer, 29, 444-51.
- Kang M, Jeong CW, Choi W, et al (2014). Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer. PLoS One, 17, 100053.
- Keizman D, Gottfried M, Ish-Shalom M, et al (2012). Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram. Oncologist, 17, 1508-14. https://doi.org/10.1634/theoncologist.2012-0125
- Kishi Y, Kopetz S, Chun YS, et al (2009). Blood neutrophil-tolymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22. https://doi.org/10.1245/s10434-008-0267-6
- Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-87 https://doi.org/10.1023/B:AGEN.0000029415.62384.ba
- Naito S (2010). Evaluation and management of prostate-specific antigenrecurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol, 35, 365-74.
- Nuhn P, Vaghasia AM, Goyal J, et al (2013). Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients withmetastatic castrationresistant prostate cancer (mCRPC) treated with first-line docetaxel. BJU Int.
- Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M (2010). Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol, 184, 873-78. https://doi.org/10.1016/j.juro.2010.05.028
- Ozyalvacli G, Yesil C, Kargi E, et al (2014).Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac J Cancer Prev, 15, 10363-6.
- Plonis J, Bokums K, Cauce V, et al (2014). Prostate cancer trends in Latvia during 1990-2012: Incidence, prevalence, mortality, and survival rates. Medicina, 50, 313-7. https://doi.org/10.1016/j.medici.2014.11.002
- Ploussard G, Agamy MA, Alenda O,, et al (2011). Impact of positive surgical margins on prostate-specific antigen failure after radicalprostatectomy in adjuvant treatment-naive patients. BJU Int, 107, 1748-54. https://doi.org/10.1111/j.1464-410X.2010.09728.x
- Shebl FM, Hsing AW, Park Y, et al (2014). Non-steroidal antiinflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One, 9, 114633. https://doi.org/10.1371/journal.pone.0114633
- Sonpavde G, Pond GR, Armstrong AJ, et al (2014). Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer, 14, 54-8.
- Sumbul AT, Sezer A, Abali H, et al (2014). Neutrophil-to lymphocyte ratio predicts PSA response, but not outcomes in patients with castration resistantprostate cancer treated with docetaxel. Int Urol Nephrol, 46, 1531-5. https://doi.org/10.1007/s11255-014-0664-7
- Tanaka N, Fujimoto K, Hirayama A, et al (2011). Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study. Int J Clin Oncol, 16, 553-9. https://doi.org/10.1007/s10147-011-0226-2
- Tanik S, Albayrak S, Zengin K, et al (2014). Is the neutrophillymphocyte ratio an indicator of progression in patients with benign prostatic hyperplasia? Asian Pac J Cancer Prev, 15, 6375-9. https://doi.org/10.7314/APJCP.2014.15.15.6375
- Teeter AE, Presti JC Jr, Aronson WJ, et al (2013). Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. Urology, 82, 53-8. https://doi.org/10.1016/j.urology.2012.10.090
- Wei Y, Jiang YZ, Qian WH (2014). Prognostic role of NLR in urinary cancers: a meta-analysis. PLoS One, 18, 92079.
피인용 문헌
- High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy vol.34, pp.6, 2016, https://doi.org/10.1007/s00345-015-1701-6
- The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6 vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3614-9
- Pretreatment Neutrophil-to-Lymphocyte Ratio vol.94, pp.41, 2015, https://doi.org/10.1097/MD.0000000000001473
- Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer vol.19, pp.3, 2016, https://doi.org/10.1038/pcan.2016.20
- Prognostic utility of neutrophil-to-lymphocyte and platelets-to-lymphocyte ratio in predicting biochemical recurrence post robotic prostatectomy vol.12, pp.8, 2018, https://doi.org/10.2217/bmm-2017-0321
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy vol.21, pp.1, 2018, https://doi.org/10.1038/s41391-017-0015-8
- The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy pp.20457634, 2019, https://doi.org/10.1002/cam4.1984